HK Stock MarketDetailed Quotes
02552 HUA MEDICINE-B
- 1.520
- -0.010-0.65%
Market Closed Dec 23 16:08 CST
1.60BMarket Cap-5.57P/E (TTM)
1.540High1.500Low474.00KVolume1.500Open1.530Pre Close718.24KTurnover0.05%Turnover RatioLossP/E (Static)1.06BShares2.55052wk High-44.71P/B1.60BFloat Cap1.03052wk Low--Dividend TTM1.06BShs Float9.000Historical High--Dividend LFY2.61%Amplitude1.030Historical Low1.515Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
HUA MEDICINE-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 45.97%102.66M | 335.31%76.61M | --70.33M | --17.6M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating income | 45.97%102.66M | 335.31%76.61M | 70.33M | 17.6M | ||||||
| Cost of sales | -108.88%-54.9M | -295.92%-39.24M | ---26.28M | ---9.91M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating expenses | -108.88%-54.9M | -295.92%-39.24M | -26.28M | -9.91M | ||||||
| Gross profit | 8.43%47.76M | 386.07%37.37M | 44.05M | 7.69M | ||||||
| Selling expenses | -15.49%-61.12M | -419.64%-79.76M | ---52.92M | ---15.35M | ---- | ---- | ---- | ---- | ---- | ---- |
| Administrative expenses | -13.11%-61.1M | 4.45%-124.15M | 21.18%-54.02M | 3.64%-129.93M | -7.90%-68.54M | 3.75%-134.84M | 1.14%-63.52M | 4.43%-140.08M | 13.46%-64.25M | -46.00%-146.58M |
| Research and development expenses | -68.70%-119.78M | -32.43%-171.54M | 1.78%-71M | 30.67%-129.53M | 26.23%-72.29M | 15.44%-186.84M | 12.71%-97.98M | 31.36%-220.96M | 32.58%-112.25M | -19.64%-321.9M |
| Special items of operating profit | 18.06%55.87M | 100.27%134.74M | 24.51%47.32M | 59,115.79%67.28M | 2,219.80%38.01M | 99.59%-114K | -133.87%-1.79M | -162.76%-27.69M | -1.51%5.29M | -40.48%44.13M |
| Operating profit | -59.83%-138.36M | -1.74%-203.33M | 15.80%-86.57M | 37.90%-199.84M | 37.04%-102.81M | 17.22%-321.78M | 4.62%-163.29M | 8.39%-388.74M | 27.26%-171.21M | -43.69%-424.36M |
| Financing cost | -9.95%-3.88M | -115.63%-7.91M | -95.51%-3.53M | 7.16%-3.67M | 9.70%-1.81M | 10.15%-3.95M | 11.04%-2M | -384.67%-4.4M | -1,641.86%-2.25M | 74.34%-907K |
| Earning before tax | -57.88%-142.24M | -3.80%-211.23M | 13.88%-90.1M | 37.52%-203.51M | 36.71%-104.62M | 17.14%-325.73M | 4.71%-165.29M | 7.56%-393.13M | 26.35%-173.46M | 88.20%-425.27M |
| After-tax profit from continuing operations | -57.88%-142.24M | -3.80%-211.23M | 13.88%-90.1M | 37.52%-203.51M | 36.71%-104.62M | 17.14%-325.73M | 4.71%-165.29M | 7.56%-393.13M | 26.35%-173.46M | 88.20%-425.27M |
| Earning after tax | -57.88%-142.24M | -3.80%-211.23M | 13.88%-90.1M | 37.52%-203.51M | 36.71%-104.62M | 17.14%-325.73M | 4.71%-165.29M | 7.56%-393.13M | 26.35%-173.46M | 88.20%-425.27M |
| Profit attributable to shareholders | -57.88%-142.24M | -3.80%-211.23M | 13.88%-90.1M | 37.52%-203.51M | 36.71%-104.62M | 17.14%-325.73M | 4.71%-165.29M | 7.56%-393.13M | 26.35%-173.46M | 88.20%-425.27M |
| Basic earnings per share | -66.67%-0.15 | -4.76%-0.22 | 18.18%-0.09 | 38.24%-0.21 | 35.29%-0.11 | 17.07%-0.34 | 5.56%-0.17 | 8.89%-0.41 | 28.00%-0.18 | 95.53%-0.45 |
| Diluted earnings per share | -66.67%-0.15 | -4.76%-0.22 | 18.18%-0.09 | 38.24%-0.21 | 35.29%-0.11 | 17.07%-0.34 | 5.56%-0.17 | 8.89%-0.41 | 28.00%-0.18 | 95.53%-0.45 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
